Found: 3
Select item for more details and to access through your institution.
B cells generated by B-1 development can progress to chronic lymphocytic leukemia.
- Published in:
- Annals of the New York Academy of Sciences, 2015, v. 1362, n. 1, p. 250, doi. 10.1111/nyas.12768
- By:
- Publication type:
- Article
Cumulative Benefit Over 52 Weeks With Deucravacitinib Versus Apremilast in Moderate to Severe Plaque Psoriasis: POETYK PSO-1 Post Hoc Analysis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 7, p. 1891, doi. 10.1007/s13555-024-01201-4
- By:
- Publication type:
- Article
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 495, doi. 10.1007/s13555-021-00649-y
- By:
- Publication type:
- Article